Boothbay Fund Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,792
| Closed | -$48.6K | – | 2137 |
|
|
2023
Q1 | $48.6K | Sell |
15,792
-1,350
| -8% | -$4.16K | ﹤0.01% | 1772 |
|
|
2022
Q4 | $90.9K | Buy |
+17,142
| New | +$90.9K | ﹤0.01% | 1573 |
|
|
2021
Q3 | – | Sell |
-13,304
| Closed | -$133K | – | 2011 |
|
|
2021
Q2 | $133K | Buy |
+13,304
| New | +$133K | ﹤0.01% | 1508 |
|
|
2021
Q1 | – | Sell |
-27,107
| Closed | -$297K | – | 1621 |
|
|
2020
Q4 | $297K | Buy |
27,107
+2,164
| +9% | +$23.7K | 0.01% | 802 |
|
|
2020
Q3 | $221K | Buy |
+24,943
| New | +$221K | 0.01% | 793 |
|